Kevin C. Gorman
2017
In 2017, Kevin C. Gorman earned a total compensation of $7.6M as Chief Executive Officer at Neurocrine Biosciences, a 43% increase compared to previous year.
Compensation breakdown
Bonus | $515,200 |
---|---|
Option Awards | $4,929,898 |
Salary | $640,000 |
Stock Awards | $1,426,920 |
Other | $44,356 |
Total | $7,556,374 |
Gorman received $4.9M in option awards, accounting for 65% of the total pay in 2017.
Gorman also received $515.2K in bonus, $640K in salary, $1.4M in stock awards and $44.4K in other compensation.
Rankings
In 2017, Kevin C. Gorman's compensation ranked 1,038th out of 14,666 executives tracked by ExecPay. In other words, Gorman earned more than 92.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,038 | 93rd |
Manufacturing | 352 | 94th |
Chemicals And Allied Products | 93 | 96th |
Drugs | 62 | 96th |
Biological Products, Except Diagnostic Substances | 10 | 97th |
Gorman's colleagues
We found four more compensation records of executives who worked with Kevin C. Gorman at Neurocrine Biosciences in 2017.
News
Neurocrine Biosciences CEO Kevin Gorman's 2021 pay rises 1% to $14M
April 7, 2022
Neurocrine Biosciences CEO Kevin Gorman's 2020 pay jumps 47% to $14M
April 9, 2021
Neurocrine Biosciences CEO Kevin Gorman's 2019 pay rises 9% to $9.5M
April 9, 2020
Neurocrine Biosciences CEO Kevin Gorman's 2018 pay rises 14% to $8.6M
April 17, 2019